Evidence map›Paper›PMID 30761126›Full record

ArticleFrontiers in immunology2019

Ethyl Pyruvate Modulates Murine Dendritic Cell Activation and Survival Through Their Immunometabolism.

Marita Chakhtoura, Robert W Chain, Priscila Y Sato, Connie C Qiu, Michael H Lee, Joseph J Meissler, Toby K Eisenstein, Walter J Koch, Roberto Caricchio, Stefania Gallucci

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Ethyl pyruvate, a versatile protector in inflammation and autoimmunity.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marita ChakhtouraLaboratory of Dendritic Cell Biology, Department of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Robert W ChainLaboratory of Dendritic Cell Biology, Department of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Priscila Y SatoCenter for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Connie C QiuLaboratory of Dendritic Cell Biology, Department of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Michael H LeeLaboratory of Dendritic Cell Biology, Department of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Joseph J MeisslerDepartment of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Toby K EisensteinDepartment of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Walter J KochCenter for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Roberto CaricchioDivision of Rheumatology, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Stefania GallucciLaboratory of Dendritic Cell Biology, Department of Microbiology-Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Temple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Munir Gunes Kutlu · 2000 to 2026
$34.6M
The role of cell death in Lupus NephritisR01AR061569 · NIAMS · TEMPLE UNIV OF THE COMMONWEALTH · PI CARICCHIO, ROBERTO · 2012 to 2016
$2.3M
Regulation of Type I IFNs in Tolerance and AutoimmunityR01AI076423 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GALLUCCI, STEFANIA · 2009 to 2013
$1.7M
NIAID NIH HHS R01 AI076423NIAMS NIH HHS R01 AR061569NIDA NIH HHS P30 DA013429
6 · The paper itself

Abstract

Attenuating the innate immunity activation could ameliorate inflammation and disease in settings such as transplant rejection or autoimmunity. Recently, a pivotal role for metabolic re-programming in TLR-induced dendritic cell (DC) activation has emerged. Ethyl pyruvate (EP), a pyruvate derivative, possesses anti-inflammatory properties

Indexed as

Energy MetabolismImmunomodulationAnimalsCells, CulturedCell SurvivalCytokinesDendritic CellsFemaleGranulocyte-Macrophage Colony-Stimulating FactorImmunity, InnateLipopolysaccharidesLymph NodesLymphocyte ActivationMiceNitric OxideProto-Oncogene Proteins c-aktCytokinesethyl pyruvateGranulocyte-Macrophage Colony-Stimulating FactorLipopolysaccharidesNitric OxideProto-Oncogene Proteins c-aktPyruvatesDC activationdendritic cellsethyl pyruvatemetabolismTLR

Identifiers

PMID30761126
PMCPMC6362406
OpenAlexW2911826535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.